Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 10 November 2025, has recommended a First Interim Dividend of Rs.1 per share (i.e.100%), subject to the approval of the shareholders.

Close

AstraZeneca Pharma India announced the resignation of Manasa. R as company secretary with effect from 28 November 2025.

Close

Britannia Industries announced that Varun Berry (DIN: 05208062), Executive Vice-Chairman, Managing Director and Chief Executive Officer has tendered his resignation on 6 November 2025. He shall be relieved from the services of the Company with effect from the close of business hours on 10 November 2025.

Close

Citurgia Biochemicals will hold a meeting of the Board of Directors of the Company on 14 November 2025.

Close

Garware Hi Tech Films will hold a meeting of the Board of Directors of the Company on 13 November 2025.

Close

GOCL Corp. will hold a meeting of the Board of Directors of the Company on 13 November 2025.

Close

Kalyani Steels announced the cessation of Sachin K. Mandlik, as an Independent Director of the Company with effect from 09 November 2025 on completion of his second term.

Close

Safari Industries (India) has allotted 1,200 equity shares under ESOP on 10 November 2025. Consequent to the aforesaid allotments, the issued, subscribed and paid-up equity share capital of the Company will increase from Rs. 9,79,82,158/- to Rs. 9,79,84,558/-.

Close

Oricon Enterprises will hold a meeting of the Board of Directors of the Company on 14 November 2025.

Close

Dr Reddys Laboratories that Jayanth Sridhar has resigned from the position of Global Head of Biologics of the Company. He will cease to be in employment and Senior Management Personnel of the Company, effective from the close of business hours on 31 January 2026.

Close